Board Meeting Outcome: Director Re-appointments and Q1 FY27 Results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.1 pts more than Nifty Microcap 250 and 6.5 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 results: standalone revenue Rs 1,693.47 lakhs (up from Rs 821.57 lakhs YoY), net profit Rs 188.60 lakhs versus a loss of Rs 215.99 lakhs YoY. Re-appointed Mrs. Snigdha Mothukuri and Mr. Nageswar Rao Yarllagadda as Whole Time Directors. Appointed Mr. Kolli Srinivas Rao as new Independent Director for 5 years. AGM scheduled for 25 September 2026.
Strong Q1 turnaround with revenue more than doubling and swing to profit. Board re-appointments maintain continuity with one new Independent Director added.